Physician profile
Jennifer B Coren
NPI 1851496673
$409,820.14
in general payments reported to CMS, 2019-2025
10 companies · $63K in 2025
The $63K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,790 · 2020: $56.24 · 2021: $65K · 2022: $114K · 2023: $108K · 2024: $54K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $141K · Travel and Lodging: $39K · Honoraria: $39K · Food and Beverage: $6,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $141,400.00 |
| Travel and Lodging | $39,209.00 |
| Honoraria | $38,838.00 |
| Food and Beverage | $6,304.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $355,564.00 | 2019-2025 | Bexsero, Penmenvy, Rotarix |
| Supernus Pharmaceuticals, INC. | $53,691.26 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $148.03 | 2024 | |
| Collegium Pharmaceutical, INC. | $99.46 | 2025 | Jornay Pm |
| Corium, LLC | $89.95 | 2023-2025 | Azstarys |
| Sanofi Pasteur INC. | $68.32 | 2022-2024 | |
| Vertical Pharmaceuticals, LLC | $59.12 | 2024-2025 | Relexxii |
| Pfizer INC. | $47.29 | 2023-2024 | |
| Tris Pharma INC | $30.36 | 2025 | Onyda Xr, Dyanavel Xr |
| Biomarin Pharmaceutical INC. | $22.35 | 2025 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Coren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.